Zhongheng Group
SSE · 600252
Market Cap$7.1B
Revenue$1.6B
Employees2843
Listed OnSSE
Ticker600252
CEO / ExecMr. Hai Run Wang
HeadquartersWuzhou
MarketMainland China
Websitewww.wz-zhongheng.com
Overview
Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology,
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.